India’s Healthcare Set for a $50 Billion Transformation as Single-Specialty Hospitals Surge – as per study

July 14, 2025

India

healthysoch

New Delhi, July 14, 2025:

India’s healthcare landscape is on the brink of a dramatic shift, with the single-specialty hospital (SSH) market projected to touch a staggering US$ 50 billion by FY30, growing at 11% CAGR. A new white paper unveiled today during India Health 2025 by Informa Markets in India and Praxis Global Alliance.

The study showcases SSHs are expected to command 40% of the market by 2028, up from 30% today—offering sharper clinical expertise, lower costs, and rapid scalability. This focused approach is tackling India’s stubborn structural gaps, from infrastructure and talent shortages to sub-par health outcomes. While India averages just 1.9 hospital beds per 1,000 people (far below the WHO target of 3), SSHs with lean, replicable models are enabling faster expansion—even in underserved regions.

What makes this trend even more newsworthy is the surge in investor confidence: private investment in SSHs soared to US$ 1.6 billion in 2023 alone, with growth-phase specialties like IVF attracting nearly US$ 1 billion between 2019 and 2023. Specialties such as eyecare and dialysis are growing at 15% CAGR each, redefining access and affordability for India’s burgeoning patient base. With healthcare demand rising sharply amid chronic disease burdens and affordability challenges—private hospitals remain 3–20x costlier than public ones—SSHs are offering a capital-efficient, high-impact solution. As India Health 2025 convenes the sector’s key players, the white paper calls for collaborative strategies to unlock this new model’s full potential, promising to reshape India’s healthcare story into one of scale, specialisation, and equitable access.

Stay informed with the latest news from HealthySoch. Sign up today for exclusive insights and updates!

We promise we never spam!

Columnists

HealthySoch

Don't Miss

PM expressed satisfaction at the rising speed of vaccinations

3.77 crore doses have been administered in the last 6

India’s first ‘Gene exon skipping therapy’ for Duchenne Muscular Dystrophy delivered in Madurai

Dr. K. Raghavan of Kenmax Multispecialty Hospital successfully delivers the